| Pharmaceutical Information |
| Drug Name |
Antivenin (micrurus fulvius) |
| Drug ID |
BADD_D00150 |
| Description |
North American Coral Snake Antivenin (Equine) is a horse-derived antivenin indicated for the treatment of envenomation caused by North American coral snake bites. It is intravenously administered so that the antivenin binds to and neutralizes coral snake venom.
The antivenin is a refined, concentrated, and lyophilized preparation of serum globulins obtained by fractionating blood from healthy horses that have been immunized with eastern coral snake (Micrurus fulvius fulvius) venom [FDA Label]. Prior to lyophilization, the product contains 0.25% phenol and 0.005% thiomerosal (mercury derivative) [FDA Label]. |
| Indications and Usage |
Indicated for the treatment of envenomation caused by North American coral snakes. |
| Marketing Status |
Not Available |
| ATC Code |
Not Available |
| DrugBank ID |
DB13883
|
| KEGG ID |
Not Available
|
| MeSH ID |
D000997
|
| PubChem ID |
Not Available
|
| TTD Drug ID |
Not Available
|
| NDC Product Code |
0008-0423 |
| Synonyms |
Antivenins | Anti-Venoms | Anti Venoms | Anti-Venin | Anti Venin | Anti-Venins | Anti Venins | Anti-Venom | Anti Venom | Antivenin | Antivenom | Antivenoms |
|
| Chemical Information |
| Molecular Formula |
Not Available |
| CAS Registry Number |
|
| SMILES |
Not Available |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
